ATE522214T1 - Therapeutisches mittel für nahrungskompetenzstörungen im magen - Google Patents

Therapeutisches mittel für nahrungskompetenzstörungen im magen

Info

Publication number
ATE522214T1
ATE522214T1 AT03745958T AT03745958T ATE522214T1 AT E522214 T1 ATE522214 T1 AT E522214T1 AT 03745958 T AT03745958 T AT 03745958T AT 03745958 T AT03745958 T AT 03745958T AT E522214 T1 ATE522214 T1 AT E522214T1
Authority
AT
Austria
Prior art keywords
group
therapeutic agent
competency
nutritional
stomach
Prior art date
Application number
AT03745958T
Other languages
English (en)
Inventor
Yugo Matsunaga
Shigeru Ueki
Raita Higashino
Masanao Kawachi
Hiroki Kato
Shiro Kobayashi
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28786350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE522214(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Application granted granted Critical
Publication of ATE522214T1 publication Critical patent/ATE522214T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
AT03745958T 2002-04-08 2003-04-08 Therapeutisches mittel für nahrungskompetenzstörungen im magen ATE522214T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002104894 2002-04-08
PCT/JP2003/004445 WO2003084537A1 (fr) 2002-04-08 2003-04-08 Agent therapeutique traitant les troubles stomacaux de competence alimentaire

Publications (1)

Publication Number Publication Date
ATE522214T1 true ATE522214T1 (de) 2011-09-15

Family

ID=28786350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745958T ATE522214T1 (de) 2002-04-08 2003-04-08 Therapeutisches mittel für nahrungskompetenzstörungen im magen

Country Status (14)

Country Link
US (4) US20050176788A1 (de)
EP (2) EP1493441B1 (de)
JP (2) JP5281226B2 (de)
KR (4) KR20050002925A (de)
CN (2) CN102125551B (de)
AT (1) ATE522214T1 (de)
AU (1) AU2003236326B2 (de)
CA (1) CA2481916C (de)
CY (1) CY1112057T1 (de)
DK (1) DK1493441T3 (de)
ES (1) ES2368732T3 (de)
PT (1) PT1493441E (de)
SI (1) SI1493441T1 (de)
WO (1) WO2003084537A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447612A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 阿考替胺水合物晶型及其制备方法和用途
CN103980226A (zh) * 2014-05-10 2014-08-13 杭州新博思生物医药有限公司 盐酸阿考替胺水合物晶型及其制备方法
CN105315225A (zh) * 2014-07-07 2016-02-10 中美华世通生物医药科技（武汉）有限公司 阿考替胺的酸加成盐及其制备方法
CN104045606B (zh) * 2014-07-11 2015-09-30 杭州新博思生物医药有限公司 一锅法制备阿考替胺盐酸盐的方法
CN109988121B (zh) * 2019-04-28 2023-01-03 梯尔希（南京）药物研发有限公司 一种阿考替胺衍生物的制备方法
AU2022312496A1 (en) 2021-07-14 2024-02-22 Blueprint Medicines Corporation Heterocyclic compounds as map4k1 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100424933B1 (ko) * 1995-05-18 2004-07-27 제리아 신야쿠 고교 가부시키 가이샤 아미노티아졸유도체,이를함유하는의약및이화합물의중간체
JPH10212271A (ja) * 1997-01-31 1998-08-11 Zeria Pharmaceut Co Ltd Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
PT994108E (pt) * 1997-06-24 2003-09-30 Zeria Pharm Co Ltd Processo de producao de derivados de 2-hidroxibenzamida
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
NZ511117A (en) * 1998-11-23 2002-11-26 Janssen Pharmaceutica Nv Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
IL146840A0 (en) * 1999-06-02 2002-07-25 Janssen Pharmaceutica Nv Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
NZ518579A (en) * 1999-11-23 2003-09-26 Janssen Pharmaceutica Nv Use of 5HT3 agonists for relaxing the fundus-a cause of gastrointestinal disorder
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
ES2273838T3 (es) * 2000-09-08 2007-05-16 Zeria Pharmaceutical Co., Ltd. Composiciones fermaceuticas que contienen derivados de aminotiazol para el tratamiento de disfunciones motoras colonicas.
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia

Also Published As

Publication number Publication date
KR20110010837A (ko) 2011-02-07
CA2481916C (en) 2013-02-26
JP2011068692A (ja) 2011-04-07
DK1493441T3 (da) 2011-10-17
CN102125551B (zh) 2015-07-22
EP1493441A4 (de) 2007-10-17
US20090156652A1 (en) 2009-06-18
JP5360075B2 (ja) 2013-12-04
KR20130101162A (ko) 2013-09-12
EP1493441B1 (de) 2011-08-31
JP5281226B2 (ja) 2013-09-04
EP1493441A1 (de) 2005-01-05
KR101423284B1 (ko) 2014-07-24
US20200375954A1 (en) 2020-12-03
CY1112057T1 (el) 2015-11-04
US20150141475A1 (en) 2015-05-21
CN1646123A (zh) 2005-07-27
CA2481916A1 (en) 2003-10-16
US20050176788A1 (en) 2005-08-11
EP2301540A1 (de) 2011-03-30
ES2368732T3 (es) 2011-11-21
SI1493441T1 (sl) 2011-12-30
AU2003236326B2 (en) 2008-02-28
PT1493441E (pt) 2011-09-28
KR20050002925A (ko) 2005-01-10
JPWO2003084537A1 (ja) 2005-08-11
WO2003084537A1 (fr) 2003-10-16
AU2003236326A1 (en) 2003-10-20
CN102125551A (zh) 2011-07-20
KR20120037035A (ko) 2012-04-18

Similar Documents

Publication Publication Date Title
EP1679309A4 (de) Antistress-arzneimittel und dessen medizinische verwendung
DK1602660T3 (da) Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer
EP1698624A4 (de) Phenylpropansäurederivate
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
BRPI0509258A (pt) composto de 8-oxoadenina 9-substituìda
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
CY1108808T1 (el) Ενωσεις μοτιλιδης
AU4396899A (en) Remedies for diabetes
BR0307905A (pt) derivados de benzotiofeno e benzofurano úteis no tratamento de distúrbios hiperproliferativos
SI1970372T1 (sl) Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli
WO2003059864A3 (en) Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
ATE522214T1 (de) Therapeutisches mittel für nahrungskompetenzstörungen im magen
WO2006068306A3 (en) COMPOSITION FOR STERILIZATION COMPRISING ω-ALKOXYPEROXYCARBOXYLIC ACID
HK1129071A1 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
BRPI0511824A (pt) radiossensibilizador
MY122570A (en) Benzamide derivatives and drugs containing the same
HK1077070A1 (en) Oligosaccharide derivative
BRPI0414580A (pt) derivado do ácido fenilacético, processos para sua produção e uso
TW200505892A (en) Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use
MA27091A1 (fr) Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
EP1500656A4 (de) Biguanidderivat und therapeutisches diabetesmittel, das dieses enthält

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1493441

Country of ref document: EP